| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/19/2005 | CA2544863A1 Selective erbb2 inhibitor/anti-erbb antibody combinations in the treatment of cancer |
| 05/19/2005 | CA2544853A1 Use of antagonist anti-cd40 antibodies for treatment of autoimmune and inflammatory diseases, and organ transplant rejection |
| 05/19/2005 | CA2544852A1 Methods of therapy for solid tumors expressing the cd40 cell-surface antigen |
| 05/19/2005 | CA2544848A1 Method of preventing virus: cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class i membrane fusogenic envelope proteins |
| 05/19/2005 | CA2544368A1 Methods of therapy for b cell-related cancers |
| 05/19/2005 | CA2544364A1 Use of antagonist anti-cd40 antibodies for treatment of chronic lymphocytic leukemia |
| 05/19/2005 | CA2543965A1 Gene expression and polymorphisms associated with lung cancer |
| 05/19/2005 | CA2543866A1 Protozoan strains of reduced virulence and use thereof |
| 05/19/2005 | CA2543639A1 System and method for transdermal vaccine delivery |
| 05/19/2005 | CA2543489A1 Human anti il-15 antibody 146b7 inducing monocytes apoptosis, therapeutical uses thereof |
| 05/19/2005 | CA2543484A1 Modulation of immune response to an immunogen with ctla-4 and tnfbp |
| 05/19/2005 | CA2543115A1 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |
| 05/19/2005 | CA2542886A1 Enhanced b cell cytotoxicity of cdim binding antibody |
| 05/19/2005 | CA2542142A1 Methods and compositions using adiponectin for treatment of cardiac disorders and for stimulation of angiogenesis |
| 05/19/2005 | CA2537759A1 Monomeric recombinant mhc molecules useful for manipulation of antigen-specific t cells |
| 05/18/2005 | EP1530973A2 Methods for inducing T cell tolerance to a tissue or organ graft |
| 05/18/2005 | EP1530972A2 Use of an agent produced from a parasite for prevention and control of diseases |
| 05/18/2005 | EP1530725A1 Materials and methods for inductions of immune tolerance |
| 05/18/2005 | EP1530724A2 Diagnosis and prevention of cancer cell invasion |
| 05/18/2005 | EP1530638A2 T-cell epitopes in staphylococcal enterotoxin b |
| 05/18/2005 | EP1530632A2 Growth factor which acts through erb b-4 rtk |
| 05/18/2005 | EP1530628A1 Process for the production of temperature-induced tumor cell lysates for use as immunogenic compounds |
| 05/18/2005 | EP1530584A2 Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses |
| 05/18/2005 | EP1530494A1 A pharmaceutical preparation containing palladium complex compounds and the uses thereof for treating cancer and autoimmune disease |
| 05/18/2005 | EP1530483A2 T cell receptor cdr3 sequences and methods for detection |
| 05/18/2005 | EP1530477A1 COMBINATION THERAPY WITH p38 MAP KINASE INHIBITORS AND THEIR PHARMACEUTICAL COMPOSITIONS |
| 05/18/2005 | EP1530474A1 Enhancing the effect of radioimmunotherapy in the treatment of tumors |
| 05/18/2005 | EP1145011B1 Compositions and methods for the diagnosis and treatment of tumor |
| 05/18/2005 | EP1100461B1 Vaccine for poultry |
| 05/18/2005 | EP0839044B1 Dendritic-like cell/tumor cell hybrids for inducing an anti-tumor response |
| 05/18/2005 | EP0584348B1 Genetic vaccine for immunodeficiency viruses |
| 05/18/2005 | CN1617935A Microorganisms and cells for diagnosis and therapy of tumors |
| 05/18/2005 | CN1617926A A structure for presenting desired peptide sequences |
| 05/18/2005 | CN1617923A Method of large scale production of hepatitis a virus |
| 05/18/2005 | CN1617888A Bispecific antibody DNA constructs for intramuscular administration |
| 05/18/2005 | CN1617884A Beta-amyloid binding factors and inhibitors thereof |
| 05/18/2005 | CN1617742A Methods for treating cancer by using tumor-derived dentrical cell inhibitory factor antagonist in combination with toll-like receptor agonist |
| 05/18/2005 | CN1617741A Method of production of purified hepatitis a virus particles and vaccine preparation |
| 05/18/2005 | CN1617740A Immunisation against chlamydia trachomatis |
| 05/18/2005 | CN1617738A Catheter composition and uses thereof |
| 05/18/2005 | CN1617736A Vaccine and method for treatment of motor neurone diseases |
| 05/18/2005 | CN1616670A 感染性克隆 Infectious clone |
| 05/18/2005 | CN1616663A O type foot and mouth disease virus DNA vaccine and its preparing method |
| 05/18/2005 | CN1616654A Inactivating and purifying method for SARS virus and method for preparing said inactivated virus vaccine and said vaccine |
| 05/18/2005 | CN1616491A Fusion protein with cold proventing and curing function and its encoding gene and use |
| 05/18/2005 | CN1616108A Novel mucous membrane vaccine for newcastle disease and its construction method |
| 05/18/2005 | CN1616097A Compound interferon inducing agent lozenge |
| 05/18/2005 | CN1616096A Method for cultivating attenuated strain pilio inactivated vaccine |
| 05/18/2005 | CN1616095A After treatment method for attenuated strain polio inactivated vaccine |
| 05/18/2005 | CN1616094A Process for preparing subunit vaccine of reovirus antigen for grass carp |
| 05/18/2005 | CN1616093A Coupled subunit vaccine for resisting sea water cultivating animal vibriosis and its preparing method and use |
| 05/18/2005 | CN1616084A Botulinum toxin pharmaceutical compositions |
| 05/18/2005 | CN1202252C Recombination proteins of Pakistani strain of hepatitis E and their use in diagnostic method and vaccines |
| 05/18/2005 | CN1202251C Infectious bursal disease virus (IBDV) polyprotein gene (VP2/VP4/VP3) eukaryon expressing plasmid and DNA vaccine |
| 05/18/2005 | CN1202134C Polysaccharide compound having immune stimulating activity |
| 05/18/2005 | CN1202127C Immunostimulant bacterial membrane tractions in cancer treatment |
| 05/18/2005 | CN1202126C Recombinant Newcastle disease virus capable of being used as embryo vaccine |
| 05/18/2005 | CN1202125C Peptide immunogen, vaccine made thereof for curing allergic reaction and its preparation method |
| 05/18/2005 | CN1201819C Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens |
| 05/18/2005 | CN1201818C Vaccine |
| 05/18/2005 | CN1201817C Tumor CT antigen immune inducing agent for treating liver cancer and its prepn |
| 05/18/2005 | CN1201728C Incorporation of active substances in carrier matrixes |
| 05/17/2005 | US6894157 Guanylate binding protein (GBP-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation |
| 05/17/2005 | US6894155 Immumodulatory protein for use in the treatment of nervous system, skin and immunological disorders |
| 05/17/2005 | US6894149 Monoclonal/polyclonal human leukocyte antigen (HLA) antibodies for use in the treatment of leukemias, lymphomas, or solid tumors of ovaries; antitumor agents; apoptosis |
| 05/17/2005 | US6894146 Anticarcinogenic drugs for prevention of disease; fusion proteins; genetic engineering |
| 05/17/2005 | US6893869 For treatment of cancer/tumors/fungal/viral infections; tumor associated antigens; genetic engineering |
| 05/17/2005 | US6893813 Methods for treatment of HIV and other infections using a T cell or viral activator and anti-retroviral combination therapy |
| 05/17/2005 | US6893644 Mixture of hepatitis antigen and carrier |
| 05/17/2005 | US6893643 Comprises exogenous nucleotide sequences which encode exogenous amino acid sequences; infection of host cell with recombinant Yellow Fever Virus provides for expression of exogenous nucleic acid and production of antigen |
| 05/17/2005 | US6893640 Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis |
| 05/17/2005 | US6893638 Methods for treating b cell lymphoma using CD80-specific antibodies |
| 05/17/2005 | US6893636 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics |
| 05/17/2005 | US6893633 Methods and compositions for promoting the maturation of monocytes |
| 05/17/2005 | CA2375673C Dna sequences derived from the genome of the papillomavirus hpv39, their application to in vitro diagnostic and to the production of immunogen compositions |
| 05/17/2005 | CA2234409C Transferrin receptor protein of moraxella |
| 05/17/2005 | CA2182393C Dna mutagenesis by random fragmentation and reassembly |
| 05/17/2005 | CA2132374C Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease |
| 05/17/2005 | CA2115151C Tau/neurofilament protein kinases pk40 and pk36 |
| 05/12/2005 | WO2005043155A1 System and method for the treatment of cancer, including cancers of the central nervous system |
| 05/12/2005 | WO2005043119A2 Methods and compositions for the identification of anti-poxvirus agents |
| 05/12/2005 | WO2005042733A1 Hbv variants detection and application |
| 05/12/2005 | WO2005042728A2 Immortalized avian cell lines for virus production |
| 05/12/2005 | WO2005042725A2 Liver cancer biomarkers |
| 05/12/2005 | WO2005042698A2 T cell epitopes useful in a hepatitis c virus vaccine and as diagnostic tools and methods for identifying same |
| 05/12/2005 | WO2005042695A2 Lipoparticles comprising proteins, methods of making, and using the same |
| 05/12/2005 | WO2005042581A2 Modified anti-cd52 antibody |
| 05/12/2005 | WO2005042576A1 Clq RELATED PROTEIN |
| 05/12/2005 | WO2005042575A2 Method for down-regulation of vegf |
| 05/12/2005 | WO2005042571A1 Method of antigen incorporation into neisseria bacterial outer membrane vesicles and resulting vaccine formulations |
| 05/12/2005 | WO2005042564A1 Flagellin fusion proteins as adjuvants or vaccines and methods of use |
| 05/12/2005 | WO2005042560A2 Non-viral delivery of compounds to mitochondria |
| 05/12/2005 | WO2005042019A1 Anti-thymocyte antiserum and use thereof to trigger b cell apoptosis |
| 05/12/2005 | WO2005042018A2 C-class oligonucleotide analogs with enhanced immunostimulatory potency |
| 05/12/2005 | WO2005042017A1 Compositions and methods for activating innate and allergic immunity |
| 05/12/2005 | WO2005042016A2 Stabilised compositions |
| 05/12/2005 | WO2005042015A1 Pharmaceutical anti-herpetic composition, method for producing a dosage form based thereon and method for the use thereof |
| 05/12/2005 | WO2005042014A1 West nile virus vaccine |
| 05/12/2005 | WO2005042013A1 Immunotherapic agent which is used for the combined treatment of tuberculosis together with other pharmaceuticals |
| 05/12/2005 | WO2005042009A1 Therapeutic regimens for baff antagonists |